Isodiol International Inc (OTCMKTS:ISOLF) has announced its second quarter financial statement for the 2019 fiscal year. The report for the period ending September 30, 2018 indicates that the hemp-based company generated total revenue of $8.03 million translating to gross profits of $4.32 million.
In its report to investors, the company outlines its major achievements during the Q2 while further projecting a prosperous future.
Isodiol announced that it has been featured in the American Health Journal – Innovations in Medicine. The announcement which first appeared on the company’s blog revealed that the segment discussed CBD in relation to its derived benefits. This among many other ventures has been Isodiol’s focus – leveraging on CBD’s benefits in treating neurological conditions and associated pain. The company’s proprietary Drug Delivery System was highlighted in the segment. The full segment is available at the company’s website for viewing.
Partnerships
In the report to investors, the company announces that through its affiliate, Iso-Sport, it has partnered with ALTIS, a Training Environment for Athletes to develop the Iso-Sport Lab. The two partners will work collaboratively to establish the positive impacts of CBD on an athlete’s health and performance. The joint research will focus on developing CBD products that will enhance athletes’ performance, recovery and quality of sleep.
Among several other announcements, the company in its report revealed that it had partnered with the powerhouse Gym under which the latter will become its designated CBD products vendor. The company picked the Powerhouse Gym probably because of its rich network. The gym operates in forty states with approximately 300 locations spread across the states.
Besides the gym, Iso-Sports agreed with UK’s MMA retailers, London fight store and Grapplestore to push its CBD Performance products.
Augmenting the company’s Board of Directors
As the company strives to stretch its influence in the Sports sector, the company appointed Marvin Washington to its Board of Directors. Isodiol plans to leverage Washington’s background in sports and finance to make notable strides in the sports industry. Leonardo Matesanz was also appointed to the company’s board of directors.
